Differential effect of lacosamide on Nav1.7 variants from responsive and non-responsive patients with small fibre neuropathy
出版年份 2020 全文链接
标题
Differential effect of lacosamide on Nav1.7 variants from responsive and non-responsive patients with small fibre neuropathy
作者
关键词
-
出版物
BRAIN
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2020-01-16
DOI
10.1093/brain/awaa016
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Switching from traditional sodium channel blockers to lacosamide in patients with epilepsy
- (2019) Dong Wook Kim et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Sodium Channels in Human Pain Disorders: Genetics and Pharmacogenomics
- (2019) Sulayman D. Dib-Hajj et al. Annual Review of Neuroscience
- The Role of Voltage-Gated Sodium Channels in Pain Signaling
- (2019) David L. Bennett et al. PHYSIOLOGICAL REVIEWS
- The Novel Activity of Carbamazepine as an Activation Modulator Extends from NaV1.7 Mutations to the NaV1.8-S242T Mutant Channel from a Patient with Painful Diabetic Neuropathy
- (2018) Chongyang Han et al. MOLECULAR PHARMACOLOGY
- Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial
- (2018) Bianca T A de Greef et al. BRAIN
- Yield of peripheral sodium channels gene screening in pure small fibre neuropathy
- (2018) Ivo Eijkenboom et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Small-fiber neuropathy: Expanding the clinical pain universe
- (2018) Maurice Sopacua et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Pain relief in a neuropathy patient by lacosamide: Proof of principle of clinical translation from patient-specific iPS cell-derived nociceptors
- (2018) Barbara Namer et al. EBioMedicine
- Associated conditions in small fiber neuropathy - a large cohort study and review of the literature
- (2017) B. T. A. de Greef et al. EUROPEAN JOURNAL OF NEUROLOGY
- Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States
- (2017) Sooyeon Jo et al. MOLECULAR PHARMACOLOGY
- CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide
- (2017) Aubin Moutal et al. PAIN
- Nav1.7-A1632G Mutation from a Family with Inherited Erythromelalgia: Enhanced Firing of Dorsal Root Ganglia Neurons Evoked by Thermal Stimuli
- (2016) Y. Yang et al. JOURNAL OF NEUROSCIENCE
- Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial–the LENSS study
- (2016) Bianca T. A. de Greef et al. Trials
- Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of NaV1.7 with Efficacy in Rodent Pain Models
- (2016) Thilo Focken et al. ACS Medicinal Chemistry Letters
- Pharmacotherapy for Pain in a Family With Inherited Erythromelalgia Guided by Genomic Analysis and Functional Profiling
- (2016) Paul Geha et al. JAMA Neurology
- Clinical Pharmacokinetic and Pharmacodynamic Profile of Lacosamide
- (2015) Willi Cawello CLINICAL PHARMACOKINETICS
- Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
- (2015) Nanna B Finnerup et al. LANCET NEUROLOGY
- Painful neuropathies: the emerging role of sodium channelopathies
- (2014) Brigitte A. Brouwer et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Sodium channel genes in pain-related disorders: phenotype–genotype associations and recommendations for clinical use
- (2014) Stephen G Waxman et al. LANCET NEUROLOGY
- Specific Binding of Lacosamide to Collapsin Response Mediator Protein 2 (CRMP2) and Direct Impairment of its Canonical Function: Implications for the Therapeutic Potential of Lacosamide
- (2014) Sarah M. Wilson et al. MOLECULAR NEUROBIOLOGY
- An atypical case ofSCN9Amutation presenting with global motor delay and a severe pain disorder
- (2013) Inge Anita Meijer et al. MUSCLE & NERVE
- Novel Mutations Mapping to the Fourth Sodium Channel Domain of Nav1.7 Result in Variable Clinical Manifestations of Primary Erythromelalgia
- (2013) Roman Cregg et al. NEUROMOLECULAR MEDICINE
- Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels
- (2013) K. McCormack et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuropathy-associated NaV1.7 variant I228M impairs integrity of dorsal root ganglion neuron axons
- (2012) Anna-Karin Persson et al. ANNALS OF NEUROLOGY
- Functional profiles of SCN9A variants in dorsal root ganglion neurons and superior cervical ganglion neurons correlate with autonomic symptoms in small fibre neuropathy
- (2012) Chongyang Han et al. BRAIN
- Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation
- (2012) Isabelle Niespodziany et al. JOURNAL OF NEUROSCIENCE RESEARCH
- The NaV1.7 sodium channel: from molecule to man
- (2012) Sulayman D. Dib-Hajj et al. NATURE REVIEWS NEUROSCIENCE
- Nav1.7-related small fiber neuropathy: Impaired slow-inactivation and DRG neuron hyperexcitability
- (2012) C. Han et al. NEUROLOGY
- Structural modelling and mutant cycle analysis predict pharmacoresponsiveness of a Nav1.7 mutant channel
- (2012) Yang Yang et al. Nature Communications
- Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy
- (2011) Catharina G. Faber et al. ANNALS OF NEUROLOGY
- Intra- and Interfamily Phenotypic Diversity in Pain Syndromes Associated with a Gain-of-Function Variant of NaV1.7
- (2011) Mark Estación et al. Molecular Pain
- Residual Undifferentiated Cells During Differentiation of Induced Pluripotent Stem Cells In Vitro and In Vivo
- (2011) Wei Fu et al. STEM CELLS AND DEVELOPMENT
- The Sodium Channel as a Target for Local Anesthetic Drugs
- (2011) Harry A. Fozzard et al. Frontiers in Pharmacology
- Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders
- (2010) Massimo Mantegazza et al. LANCET NEUROLOGY
- A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia
- (2009) Tanya Z. Fischer et al. ANNALS OF NEUROLOGY
- Efficacy and Safety of Lacosamide in Diabetic Neuropathic Pain
- (2009) James P. Wymer et al. CLINICAL JOURNAL OF PAIN
- Lacosamide in Painful Diabetic Neuropathy: An 18-Week Double-Blind Placebo-Controlled Trial
- (2009) Aziz Shaibani et al. JOURNAL OF PAIN
- Long-term oral lacosamide in painful diabetic neuropathy: A two-year open-label extension trial
- (2008) Aziz Shaibani et al. EUROPEAN JOURNAL OF PAIN
- Differential Block of Sensory Neuronal Voltage-Gated Sodium Channels by Lacosamide [(2R)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide], Lidocaine, and Carbamazepine
- (2008) P. L. Sheets et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started